Skip to main content
Clinical Trials/RBR-9x5zrgm
RBR-9x5zrgm
Recruiting
未知

Influence of different photobiomodulation protocols on prevention of chemotherapy-induced dygeusia in patients with breast cancer treated with doxorubicine-cyclophosphamide and taxans: Phase III clinical trial, randomized, triple blind.

niversidade Federal do Ceará0 sitesDecember 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast malignant neoplasm
Sponsor
niversidade Federal do Ceará
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2023
End Date
March 13, 2024
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
niversidade Federal do Ceará

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years old; breast cancer stages II, III and IV; adjuvant, neoadjuvant or palliative; treatment with drugs Doxorubicin, Cyclophosphamide and Taxol

Exclusion Criteria

  • Radiotherapy to the head and neck; smokers; anemia; untreated diabetes mellitus; after COVID\-19

Outcomes

Primary Outcomes

Not specified

Similar Trials